Announcement PDF Enlitic, Inc. 1635 Foxtrail Drive, Suite 111A Loveland, CO 80538 www.enlitic.com 4 September 2026 Completion of Security Purchase Plan Enlitic, Inc. (ASX: ENL) (“Enlitic” or the “Company”) confirms the completion of its non-underwritten security purchase plan (“SPP”) following the close of the SPP offer at 5.00pm (Melbourne time) on Friday, 28 August 2026. This follows Enlitic’s successful approximately A$15 million conditional placement (“Conditional Placement”) announced to ASX on Friday, 3 July 2026 which successfully completed on Thursday, 6 August 2026. A total of approximately A$739,000 was raised under the SPP, with 184,750,000 new fully paid CHESS depositary interests (“CDIs”) (“New CDIs”) expected to be issued to participating eligible Enlitic CDI holders today at an issue price of A$0.004 per New CDI, calculated as the lower of: (i) A$0.004 (being the same issue price paid by institutional and sophisticated investors under the Conditional Placement); and (ii) a 2.5% discount to the volume weighted average price of CDIs traded on ASX during the five trading days up to and including the closing date of the SPP, rounded to the nearest A$0.001. New CDIs issued under the SPP will rank equally with existing Enlitic CDIs from their date of issue. Funds raised from the SPP will be used for general corporate and working capital purposes and flexibility in implementing Enlitic’s strategic commercial objectives (refer to the Company’s announcement and Investor Presentation provided to the ASX on Friday, 3 July 2026 for further information). The trading of New CDIs issued under the SPP is expected to commence on Monday, 7 September 2026 and holding statements are expected to be despatched to participating eligible Enlitic CDI holders on Tuesday, 8 September 2026. Please view the announcement here on our website: https://enlitic.com/link/Pb6OkP ENDS This announcement was authorised for release by the Board of Enlitic, Inc. Enquiries Enlitic Investor Relations Australia: invest_au@enlitic.com Six Degrees Investor Relations Henry Jordan Henry.jordan@sdir.com.au +61 431 271 538 About Enlitic Enlitic is a software company that uses artificial intelligence to develop software products that manage medical imaging data in radiology (such as MRI, CT scans, Xray and ultrasound images) and licences such products to healthcare providers. Enlitic’s products (including its current product offering and product suite under development) seek to standardise, protect, integrate, and analyse data to create the foundation of a real-world evidence platform that can improve clinical workflows, increase efficiencies, and expand capacity. Read more at enlitic.com. Enlitic’s CDIs are traded on ASX in reliance on the safe harbour provisions of Regulation S under the US Securities Act of 1933 as amended, and in accordance with the procedures established pursuant to the provisions of a no action letter dated 7 January 2000 given to ASX by the staff at the US Securities and Exchange Commission. The relief was given subject to certain procedures and conditions described in the no action letter. One of the conditions is that the issuer provides notification of the Regulation S status of its securities in communications such as this announcement. Forward-looking statements Certain statements made during or in connection with this announcement contain or comprise certain forward-looking statements regarding the Company, its projected cash flow, financial performance, its customer contracts and customer pipeline and product development. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such expectations are only predictions and are subject to inherent risks and uncertainties which could cause actual values, results, performance or achievements to differ materially from those expressed, implied or projected in any forward looking statements and no assurance can be given that such expectations will prove to have been correct. Accordingly, results could differ materially from those set out in the forward-looking statements as a result of, among other factors, changes in economic and market conditions, delays or changes in product development and realisation of customer pipeline, changes in demand, success of business and operating initiatives, changes in the regulatory environment and other government actions, fluctuations in exchange rates and business and operational risk management. To the maximum extent permitted by law, each of the Company, its officers, employees and advisers expressly disclaim any responsibility for the accuracy or completeness of the material contained in these forward-looking statements and excludes all liability whatsoever (including in negligence) for any loss or damage which may be suffered by any person as a consequence of any information in forward-looking statements or any error or omission. The Company undertakes no obligation to update publicly or release any revisions to these forward-looking statements to reflect events or circumstances after today’s date or to reflect the occurrence of unanticipated events other than required by the applicable laws, including the ASX Listing Rules. Accordingly, you should not place undue reliance on any forward-looking statement.